AGA Family of Websites: Gastro.org
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
Medical Billing
June 26, 2020

New COVID-19 relief for QPP participants in 2020

Medicare announced new flexibilities for clinicians participating in the QPP MIPS in 2020 in response to the COVID-19 public health emergency.
Share on facebook
Share on twitter
Share on linkedin
Share on email

Summary of the flexibilities available

Clinicians significantly impacted by the public health emergency (PHE) may submit an Extreme & Uncontrollable Circumstances Application to reweight any or all of the Merit-based Incentive Payment System (MIPS) performance categories.

  • Those requesting relief via the application will need to provide a justification of how their practice has been significantly impacted by the public health emergency.

There are two ways MIPS eligible clinicians or groups can receive credit for this new COVID-19 Clinical Trials improvement activity added in April:

  • A clinician may participate in a COVID-19 clinical trial and have those data entered into a data platform for that study.
  • A clinician participating in the care of COVID-19 patients may submit clinical COVID-19 patient data to a clinical data registry for purposes of future study.

For more information

Visit the Quality Payment Program (QPP) COVID-19 Response webpage or review the COVID-19 Fact Sheet to learn more about changes to the Quality Payment Program in response to the COVID-19 pandemic.

Review the 2020 Exception Applications Fact Sheet and QPP Exception Applications webpage for more information about submitting an Extreme & Uncontrollable Circumstances Application.

Read more about the COVID-19 clinical trials improvement activity in the 2020 Improvement Activities Inventory.

Contact the Quality Payment Program at 1-866-288-8292 or by e-mail at: QPP@cms.hhs.gov.

Make sure your voice is heard on Capitol Hill
AGA Advocacy
Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.